1. Home
  2. MATH vs QTTB Comparison

MATH vs QTTB Comparison

Compare MATH & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$1.09

Market Cap

53.8M

Sector

Finance

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$5.93

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
QTTB
Founded
2015
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.8M
44.3M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
MATH
QTTB
Price
$1.09
$5.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
26.4K
359.5K
Earning Date
07-30-2025
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.78
EPS
N/A
2.42
Revenue
N/A
$53,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
$2.33
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.38
52 Week High
$4.17
$8.05

Technical Indicators

Market Signals
Indicator
MATH
QTTB
Relative Strength Index (RSI) 41.28 49.08
Support Level $1.00 $5.51
Resistance Level $1.30 $6.37
Average True Range (ATR) 0.09 0.91
MACD 0.01 -0.19
Stochastic Oscillator 21.12 14.60

Price Performance

Historical Comparison
MATH
QTTB

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: